Home / Oncology / Trypanosomiasis Global Clinical Trials Review, H1, 2015

Trypanosomiasis Global Clinical Trials Review, H1, 2015

Published: Jun 2015 | No Of Pages: 82 | Published By: GlobalData

Trypanosomiasis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, ¬ďTrypanosomiasis Global Clinical Trials Review, H1, 2015" provides an overview of Trypanosomiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Trypanosomiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data¬ís proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Trypanosomiasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Trypanosomiasis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Trypanosomiasis to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Trypanosomiasis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Trypanosomiasis Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Medecins Sans Frontieres 32
Clinical Trial Overview of Medecins Sans Frontieres 32
Icddr,b 33
Clinical Trial Overview of Icddr,b 33
Sanofi 34
Clinical Trial Overview of Sanofi 34
Knight Therapeutics Inc. 35
Clinical Trial Overview of Knight Therapeutics Inc. 35
Aeterna Zentaris Inc. 36
Clinical Trial Overview of Aeterna Zentaris Inc. 36
Immtech Pharmaceuticals, Inc. 37
Clinical Trial Overview of Immtech Pharmaceuticals, Inc. 37
Lifecare Innovations Private Limited 38
Clinical Trial Overview of Lifecare Innovations Private Limited 38
GVK Biosciences Private Limited 39
Clinical Trial Overview of GVK Biosciences Private Limited 39
Fast-Track Drugs & Biologics, LLC 40
Clinical Trial Overview of Fast-Track Drugs & Biologics, LLC 40
Eisai Co., Ltd. 41
Clinical Trial Overview of Eisai Co., Ltd. 41
Clinical Trial Overview of Top Institutes / Government 42
Drugs for Neglected Diseases initiative 42
Clinical Trial Overview of Drugs for Neglected Diseases initiative 42
Mashhad University of Medical Sciences 45
Clinical Trial Overview of Mashhad University of Medical Sciences 45
U.S. Army Medical Research and Materiel Command 46
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 46
Banaras Hindu University 47
Clinical Trial Overview of Banaras Hindu University 47
Infectious Disease Research Institute 48
Clinical Trial Overview of Infectious Disease Research Institute 48
Tehran University of Medical Sciences 49
Clinical Trial Overview of Tehran University of Medical Sciences 49
Hospital Universitrio Professor Edgard Santos 50
Clinical Trial Overview of Hospital Universitrio Professor Edgard Santos 50
AB foundation 51
Clinical Trial Overview of AB foundation 51
Oswaldo Cruz Foundation 52
Clinical Trial Overview of Oswaldo Cruz Foundation 52
The National Institute of Allergy and Infectious Diseases 53
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 53
Five Key Clinical Profiles 54
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82

List of Tables
Trypanosomiasis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Trypanosomiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Trypanosomiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Trypanosomiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Trypanosomiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Trypanosomiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Trypanosomiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Trypanosomiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Trypanosomiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Trypanosomiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Trypanosomiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Trypanosomiasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Trypanosomiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Trypanosomiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Trypanosomiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Trypanosomiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Trypanosomiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Trypanosomiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Trypanosomiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Trypanosomiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Trypanosomiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medecins Sans Frontieres, 2015* 32
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Icddr,b, 2015* 33
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 34
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Knight Therapeutics Inc., 2015* 35
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeterna Zentaris Inc., 2015* 36
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Immtech Pharmaceuticals, Inc., 2015* 37
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lifecare Innovations Private Limited, 2015* 38
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GVK Biosciences Private Limited, 2015* 39
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fast-Track Drugs & Biologics, LLC, 2015* 40
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 41
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Drugs for Neglected Diseases initiative, 2015* 42
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2015* 45
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2015* 46
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Banaras Hindu University, 2015* 47
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Infectious Disease Research Institute, 2015* 48
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 49
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitrio Professor Edgard Santos, 2015* 50
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AB foundation, 2015* 51
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Oswaldo Cruz Foundation, 2015* 52
Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 53

List of Figures
Trypanosomiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Trypanosomiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Trypanosomiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Trypanosomiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Trypanosomiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Trypanosomiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Trypanosomiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Trypanosomiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Trypanosomiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Trypanosomiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Trypanosomiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Trypanosomiasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Trypanosomiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Trypanosomiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Trypanosomiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Trypanosomiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Trypanosomiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Trypanosomiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Trypanosomiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 81

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +